Overall rank by patents
#5,926
Across all tracked assignees
USPTO PatentsView assignee record - 57 granted patents across 34 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B67D (DISPENSING, DELIVERING OR TRANSFERRING LIQUIDS, NOT OTHERWISE PROVIDED FOR).
The verdict
Cornelius holds 57 US patents across 34 technology areas, rank #5,926 of 50,000 tracked assignees.
Cornelius, Inc. has been granted 57 US utility patents between 2015 and 2021, placing Cornelius, Inc. at rank #5,926 across all assignees tracked by PlainPatent. This portfolio spans 34 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.9 claims per patent with primary concentration in B67D (DISPENSING, DELIVERING OR TRANSFERRING LIQUIDS, NOT OTHERWISE PROVIDED FOR). As a US Corporation, Cornelius, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Cornelius sits between Ceva Sante Animale (57 patents, rank #5,922) and Deliflor Royalties B.v. (57 patents, rank #5,930) - the closest US assignees by grant volume. The composite Innovation Score of 43.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 42 in the 2015–2019 window, a -64% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cornelius, Inc.'s 14.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 34 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cornelius, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ceva Sante Animale
57 patents
ChampionX USA Inc.
57 patents
Clearfield, Inc.
57 patents
Computational Systems, Inc.
57 patents
D B Industries, LLC
57 patents
DAEWOONG PHARMACEUTICAL CO., LTD.
57 patents
DAIKIN EUROPE N.V.
57 patents
DELIFLOR ROYALTIES B.V.
57 patents
Cornelius, Inc.
57 patents
What this shows Cornelius holds 57 patents at rank #5,926, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,926 in granted patent volume.
Other assignees with the most granted patents in Cornelius's primary technology class.
Cornelius's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 28% higher than 72% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 11 | 19.3% |
| 2016 | 11 | 19.3% |
| 2017 | 3 | 5.3% |
| 2018 | 7 | 12.3% |
| 2019 | 10 | 17.5% |
| 2020 | 10 | 17.5% |
| 2021 | 5 | 8.8% |
Top 15 of 34 technology areas
Overall rank by patents
#5,926
Across all tracked assignees
43.6 out of 100
How to use this portfolio
Cornelius's 57 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.